Featured
Last news
Basatne Launches ORBT to Transform the Global Digital Payouts Market
New fintech platform converts refunds, trade-ins, and incentives into instant digital value, aligning with the global shift toward mobile-first, closed-loop spending.
TRNR Completes Acquisition of Ergatta, Confirms Increased 2026 Pro Forma Revenue Guidance of $30m+
Ergatta's 2026 Revenue Expected to Exceed $10 Million with Approximately 30% EBITDA MarginTRNR received $6.4 Million on March 4th from Sportstech and paid $1.8 Million to Ergatta shareholders to Close AcquisitionErgatta is Expected to Generate Cashflow for TRNR in 2026 in Excess of Closing Cash Consideration
Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts
SAN FRANCISCO, CA / ACCESS Newswire / March 11, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present virtually on Thursday, March 12, 2026 at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com.
Dr. Sean Doherty Recognized as Boston Magazine Top Doctors(TM) 2026 - Plastic Surgery
Board-certified plastic surgeon earns Boston Magazine Top Doctors™ recognition for the tenth consecutive year through peer nomination.
Prysmian Strengthens Grid Resilience Through Sustainable Materials Innovation
HIGHLAND HEIGHTS, KY / ACCESS Newswire / March 11, 2026 / Prysmian, Prysmian, a world leader in the energy transition and digital transformation, today announced continued progress in the evolution of its power distribution and high‑voltage cable portfolio, reinforcing its commitment to sustainable innovation and long‑term grid resilience.
NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete
SHELTON, CT / ACCESS Newswire / March 11, 2026 / NanoViricides, Inc. (AMEX:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, is pleased to announce that it will be presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, Florida.
CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline
Newly formed executive team initiates global search for differentiated therapeutic assets for neurology and oncology indications, two of biopharma's largest and fastest-growing marketsStrategic transformation driven by a comprehensive data analysis will enable new executive team to leverage decades of experience in these therapeutic areasCompany pivoting from a singular focus on glioblastoma and will explore out-licensing of legacy assets berubicin and TPI 287
Wellgistics Strengthens PharmacyChain(TM) with Insurance Eligibility & Benefits Verification Capabilities
Medical insurance eligibility and benefits verification (EBV) is a core health technology capability necessary for PharmacyChain™ to gain market adoptionEBV services offering enabled with preferred pricing being made immediately available to providers, partners and the Wellgistics Pharmacy NetworkEBV market expected to grow from $2.39 billion in 2025 to $3 billion in 2030 according to The Business Research Company1
Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases
Patent momentum expands Revive's bucillamine franchise across medical countermeasures, infectious diseases and additional high-value strategic applications
Mosaic and Rainbow Rare Earths Advance Uberaba Rare Earths Project in Brazil
TAMPA, FL / ACCESS Newswire / March 11, 2026 / Mosaic Fertilizantes P&K Limitada, a subsidiary of the Mosaic Company ("Mosaic") and Rainbow Rare Earths Limited ("Rainbow") have completed a favorable preliminary economic assessment and entered into a joint project development agreement to advance the Uberaba rare earths project in Minas Gerais, Brazil.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - March 11
InterContinental Hotels Group PLC (the "Company")Purchase of own shares
Police say deadly Swiss bus fire could be deliberate
A bus caught fire in western Switzerland on Tuesday killing at least six people and injuring five others in what police said may have been a deliberate act.
Family of Canada mass shooting victim sues OpenAI
The family of a girl gravely injured during a mass shooting in Canada is suing OpenAI over the company's failure to notify police about the killer's troubling activity on its ChatGPT chatbot, lawyers said Tuesday.
Gunfire at US consulate in Toronto a 'national security incident': police
Two men fired multiple shots at the US consulate in Toronto early Tuesday in what police described as a "national security incident," prompting beefed-up protection for US and Israeli diplomatic buildings in the city.
Middle East war : global economic fallout
Here are the latest economic events in the Middle East war on Tuesday:
Journalists face restrictions, detention covering Mideast war
Journalists covering the war in the Middle East are facing increasing restrictions and censorship imposed by governments and armed groups, with reporters being stopped and questioned or even detained, a survey of AFP bureau chiefs from the region showed.
Nicaragua ramping up repression of exiles: UN experts
While ramping up its repression at home, Nicaragua's government is also going after exiles abroad, with hundreds if not thousands of people affected, UN investigators said Tuesday.
Disappearances multiply in strongman Doumbouya's Guinea
More than a year after his abduction in Guinea by men in fatigues, Abdoul Sacko is still grappling with the physical and psychological scars of the torture he endured.
CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth
SAN DIEGO, CA / ACCESS Newswire / March 10, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in proven, science-backed natural ingredients and products, today announced that it has modified its existing outstanding notes to include a conversion feature pursuant to which the outstanding balance of the notes may be converted into common shares of the Company at a fixed conversion price of $0.06 per share.
The $30 Billion CBD Question: Should Medicare Reimburse Cannabis Products Without FDA Approval?
"Medicare was built on evidence-based medicine," said Duane Boise, CEO of MMJ International Holdings. "If cannabinoid therapies are going to be reimbursed by federal healthcare programs, they should meet the same scientific standards every other drug must meet-rigorous clinical trials, validated manufacturing, and FDA oversight."
Travel Nevada Invites Visitors to Experience Spring and Summer Across the Silver State
Unique events and outdoor adventures showcase Nevada's rich spirit and culture
As Spring Awakens, New Children's Book 'Are You Here?' Invites Families to Notice the Signs of Love That Never Leave Us
NASHVILLE, TN / ACCESS Newswire / March 10, 2026 / As spring returns and the natural world begins to bloom again, a new children's book encourages families to pause, reflect, and notice the quiet signs of love that surround us every day. In Are You Here?, author Jenny Robinson Clark makes her children's book debut with a gentle exploration of one of life's most tender and enduring questions: Are our loved ones still with us after they pass?
Path Fertility Releases its Company Facts Sheet
SALT LAKE CITY, UT / ACCESS Newswire / March 10, 2026 / Path FertilityTM, an epigenetics-driven fertility technology company, today unveiled the Path Fertility Facts Sheet, a copy of which is embedded below within this news release.
For Couples in "Fertility Limbo," a Real-World Study Published by JARG Finds "Normal" Semen Analysis May Not Tell the Whole Story
A peer-reviewed, multi-clinic study published in the Journal of Assisted Reproduction and Genetics suggests an epigenetic sperm-quality profile can add missing information for infertile couples and clinicians, especially when they are considering IUI (Intrauterine Insemination), IVF (In Vitro Insemination), and/or ICSI (Intracytoplasmic Sperm Injection).Path Fertility's review of this capstone research, including the data gathered from preceding studies, confirms clinical data show that "up to 25% of men with a ‘normal' Semen Analysis result have sperm that are incapable of producing a healthy pregnancy without intervention via advanced fertility techniques."
VSee Unveils World's First Autonomous Telehealth AI Robot at HIMSS 2026
Autonomous, AI-Powered Robot Navigates Directly to Patients' Bedsides - No Staff Escort Required
Farrington Capital Group Names Stuart Fine Acting CEO of ReadySetFundGrow, Remergify Founder to Lead Operational Buildout While Uniting Two Organizations Around a Shared Mission
The appointment signals a bold next step for RSFG - bringing the leadership, team, and community-first vision of Remergify directly into the organization as it moves from concept to construction
JinIX Foundation Marks a New Chapter with a Partner Event at Its Retreat Center
JinIX Foundation retreat brings partners together through art, etiquette, wellness, and community while celebrating a new home for meaningful connection and future collaboration.
The Digital Dept. Signs Reality TV Show Stars, Top Beauty Creators, And More!
LOS ANGELES, CALIFORNIA / ACCESS Newswire / March 10, 2026 / The Digital Dept., a subsidiary of Dolphin (NASDAQ:DLPN) announced an expansion of its Talent Division through several new clients, including reality TV show stars, beauty creators, Netflix actors, and more! The talent division represents more than 300 top digital creators and celebrities in their brand partnerships and digital presence.
Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing
- Kyra Peckaitis will lead the launch of Dermata's recently announced Tome skincare brand -
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack
Convenient Size at the Convenience Store
374Water Announces 5-Year Agreement with the City of Orlando Approval to Launch Licensed Waste Destruction Services Hub
Orlando Approves License to Launch AirSCWO Technology Use for Waste Destruction
Arthritis Foundation Announces 2026 Cycling Experiences With Three Ways to Ride and Support the Arthritis Community
ATLANTA, GA / ACCESS Newswire / March 10, 2026 / The Arthritis Foundation is preparing for its 2026 Cycling Experiences, featuring the Carolina Hills Classic Bike Tour, May 14-17, the California Coast Classic Bike Tour, Sept. 26-Oct. 3, and an expanded "Ride Your Way" option. Together, these three ways to participate give cyclists and supporters nationwide the opportunity to challenge themselves, build community and raise critical funds for the nearly 60 million adults and children in the U.S. who have been diagnosed with arthritis.